Not manycompaniesthis size with2 late stageassetsI/ONTAKis our leadassetWe intendto submita BLA in2H 2022We haveenough cashto go wellinto 2023I/ONTAKwas thebest deal Iever madeInsidersinvested$26.5mMino-WrapAn actualiMSCupdateWe will openupinternationalsites forMino-Lok trialI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Hemorrhoidsis a $2BmarketThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"I'm ashareholdermyselfOnly biotechwith 2 Myron'son theleadershipteamThere are noFDAapproveddrugs to treathemorrhoidsWe willhaveexclusivityMyron Holubiakand I founded aprivatecompany in2013Mino-Lokpotentialmarket>$1BWe expect tofinish theMino-Loktrial this yearI/ONTAK'spotentialmarket is>$300mOur Halo-Lido trial willhave finalpatient byend of 2022We had aphase 2btrial with100%efficacyMino-Lokis our leadassetI won't diluteshareholdersNot manycompaniesthis size with2 late stageassetsI/ONTAKis our leadassetWe intendto submita BLA in2H 2022We haveenough cashto go wellinto 2023I/ONTAKwas thebest deal Iever madeInsidersinvested$26.5mMino-WrapAn actualiMSCupdateWe will openupinternationalsites forMino-Lok trialI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Hemorrhoidsis a $2BmarketThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"I'm ashareholdermyselfOnly biotechwith 2 Myron'son theleadershipteamThere are noFDAapproveddrugs to treathemorrhoidsWe willhaveexclusivityMyron Holubiakand I founded aprivatecompany in2013Mino-Lokpotentialmarket>$1BWe expect tofinish theMino-Loktrial this yearI/ONTAK'spotentialmarket is>$300mOur Halo-Lido trial willhave finalpatient byend of 2022We had aphase 2btrial with100%efficacyMino-Lokis our leadassetI won't diluteshareholders

Leonard Mazur HCW Conference - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Not many companies this size with 2 late stage assets
  2. I/ONTAK is our lead asset
  3. We intend to submit a BLA in 2H 2022
  4. We have enough cash to go well into 2023
  5. I/ONTAK was the best deal I ever made
  6. Insiders invested $26.5m
  7. Mino-Wrap
  8. An actual iMSC update
  9. We will open up international sites for Mino-Lok trial
  10. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  11. Hemorrhoids is a $2B market
  12. The name Citius comes from the Olympic motto "Citius,Altius Fortius"
  13. I'm a shareholder myself
  14. Only biotech with 2 Myron's on the leadership team
  15. There are no FDA approved drugs to treat hemorrhoids
  16. We will have exclusivity
  17. Myron Holubiak and I founded a private company in 2013
  18. Mino-Lok potential market >$1B
  19. We expect to finish the Mino-Lok trial this year
  20. I/ONTAK's potential market is >$300m
  21. Our Halo-Lido trial will have final patient by end of 2022
  22. We had a phase 2b trial with 100% efficacy
  23. Mino-Lok is our lead asset
  24. I won't dilute shareholders